HuGE Literature Finder
Records
1
-
30
| Rs3746444 T>C locus in miR-499 increases the susceptibility to hepatocellular carcinoma: A meta-analysis 14812 subjects. World journal of gastrointestinal oncology 2023 1 15 (1): 171-185. Jiang Jia-Kai, Chen Han-Shen, Tang Wei-Feng, Chen Yu, Lin Ji |
Genetic variation in TERT modifies the risk of hepatocellular carcinoma in alcohol-related cirrhosis: results from a genome-wide case-control study.
Gut 2022 Jul . Buch Stephan, Innes Hamish, Lutz Philipp Ludwig, Nischalke Hans Dieter, Marquardt Jens U, Fischer Janett, Weiss Karl Heinz, Rosendahl Jonas, Marot Astrid, Krawczyk Marcin, Casper Markus, Lammert Frank, Eyer Florian, Vogel Arndt, Marhenke Silke, von Felden Johann, Sharma Rohini, Atkinson Stephen Rahul, McQuillin Andrew, Nattermann Jacob, Schafmayer Clemens, Franke Andre, Strassburg Christian, Rietschel Marcella, Altmann Heidi, Sulk Stefan, Thangapandi Veera Raghavan, Brosch Mario, Lackner Carolin, Stauber Rudolf E, Canbay Ali, Link Alexander, Reiberger Thomas, Mandorfer Mattias, Semmler Georg, Scheiner Bernhard, Datz Christian, Romeo Stefano, Ginanni Corradini Stefano, Irving William Lucien, Morling Joanne R, Guha Indra Neil, Barnes Eleanor, Ansari M Azim, Quistrebert Jocelyn, Valenti Luca, Müller Sascha A, Morgan Marsha Yvonne, Dufour Jean-François, Trebicka Jonel, Berg Thomas, Deltenre Pierre, Mueller Sebastian, Hampe Jochen, Stickel Fel |
| Association of RASSF1A Ala133Ser polymorphism with cancer risk: a updated meta-analysis involving 7362 subjects. Nucleosides, nucleotides & nucleic acids 2022 Jun 1-15. Yin Guang, Kong Wencheng, Liu Xinchun, Zheng Sixin, Ying Rongchao, Shan Yuqia |
| Contribution of DNA methylation to the risk of hepatitis C virus-associated hepatocellular carcinoma: A meta-analysis. Pathology, research and practice 2022 9 238 154136. Zhang Cheng, Zhang Wangjian, Yuan Zhijun, Yang Wenjun, Hu Xiangrong, Duan Shiwei, Wei Qich |
| Diagnostic performance of circulating tumor DNA as a minimally invasive biomarker for hepatocellular carcinoma: a systematic review and meta-analysis. PeerJ 2022 11 10 e14303. Li Jia Jie, Lv Yanqing, Ji Huif |
| Methylation-sensitive high-resolution melting analysis of the USP44 promoter can detect early-stage hepatocellular carcinoma in blood samples. BMB reports 2022 8 55 (11): 553-558. Kim Si-Cho, Kim Jiwon, Kim Da-Won, Choi Yanghee, Park Kyunghyun, Cho Eun Ju, Yu Su Jong, Kim-Ha Jeongsil, Kim Young-Jo |
| The combined signatures of hypoxia and cellular landscape provides a prognostic and therapeutic biomarker in hepatitis B virus-related hepatocellular carcinoma. International journal of cancer 2022 4 151 (5): 809-824. Chen Shipeng, Gao Yuzhen, Wang Ying, Daemen To |
| The relationship between NTCP gene varieties and the progress of liver disease after HBV infection: an updated systematic review and meta-analysis. The American journal of the medical sciences 2022 4 364 (2): 207-219. He Chuan, He Hong-Yan, Sun Chang-Feng, Ojha Suvash Chandra, Wang Hang, Deng Cun-Liang, Sheng Yun-Ji |
| Associations between methylenetetrahydrofolate reductase polymorphisms and hepatocellular carcinoma risk: An update meta-analysis and trial sequential analysis. Medicine 2021 Oct 100 (41): e27527. Wang Binfeng, Ma Miaomiao, Guo Xiaojun, Yan Yan, Li La |
| Evaluation of interleukin 8 polymorphisms (-251T/A and +781C/T) in patients with hepatocellular carcinoma: a meta-analysis. Clinical and experimental hepatology 2021 Sep 7 (3): 278-285. Aleagha Omid Emami, Moeinzadeh Forouzan, Shokouh Seyedeh Farnaz Moeini, Do?an Erkan, Sadeghi Maso |
| EGF rs4444903 polymorphism is associated with risk of HCV-related cirrhosis and HBV/HCV-related hepatocellular carcinoma. International journal of clinical oncology 2021 Jul . Wang Jia, Zhong Yanlin, Meng Guix |
| Variation and expression of HLA-DPB1 gene in HBV infection. Immunogenetics 2021 Mar . Ou Guojin, Liu Xiao, Xu Haixia, Ji Xin, Liu Xiaojuan, Wang J |
| Association of HSD17B13 rs72613567: TA allelic variant with liver disease: review and meta-analysis. BMC gastroenterology 2021 12 21 (1): 490. Tang Shan, Zhang Jing, Mei Ting-Ting, Zhang Wen-Yan, Zheng Su-Jun, Yu Hai-B |
| MBOAT7-TMC4 rs641738 Is Not Associated With the Risk of Hepatocellular Carcinoma or Persistent Hepatitis B Infection. Frontiers in oncology 2021 11 639438. Wang Peng, Li Ying, Li Lu, Zhong Rong, Shen |
| MiRNA Polymorphisms and Hepatocellular Carcinoma Susceptibility: A Systematic Review and Network Meta-Analysis. Frontiers in oncology 2021 2 10 562019. Zhang Qimeng, Xu Xueying, Wu Mingcheng, Qin Tiantian, Wu Shaoning, Liu Hong |
| Prognostic and Clinicopathological Value of Human Leukocyte Antigen G in Gastrointestinal Cancers: A Meta-Analysis. Frontiers in oncology 2021 5 11 642902. Peng Yongjia, Xiao Jian, Li Wenyun, Li Shuna, Xie Binbin, He Jiang, Liu Chaoq |
| The rs429358 Locus in Apolipoprotein E Is Associated With Hepatocellular Carcinoma in Patients With Cirrhosis. Hepatology communications 2021 12 6 (5): 1213-1226. Innes Hamish, Nischalke Hans Dieter, Guha Indra Neil, Weiss Karl Heinz, Irving Will, Gotthardt Daniel, Barnes Eleanor, Fischer Janett, Ansari M Azim, Rosendahl Jonas, Lin Shang-Kuan, Marot Astrid, Pedergnana Vincent, Casper Markus, Benselin Jennifer, Lammert Frank, McLauchlan John, Lutz Philip L, Hamill Victoria, Mueller Sebastian, Morling Joanne R, Semmler Georg, Eyer Florian, von Felden Johann, Link Alexander, Vogel Arndt, Marquardt Jens U, Sulk Stefan, Trebicka Jonel, Valenti Luca, Datz Christian, Reiberger Thomas, Schafmayer Clemens, Berg Thomas, Deltenre Pierre, Hampe Jochen, Stickel Felix, Buch Steph |
| Association between interleukin 6 polymorphisms (rs1800796, rs1800795, rs2069837, rs17147230, and rs1800797) and hepatocellular carcinoma susceptibility: a meta-analysis. Clinical and experimental hepatology 2020 Dec 6 (4): 359-366. Aleagha Omid Emami, Oltulu Pembe, Sadeghi Maso |
| Association of interleukin-6 gene polymorphisms with the risk of hepatocellular carcinoma: An up-to-date meta-analysis. Medicine 2020 Dec 99 (50): e23659. An Pei-Pei, Feng Li-Na, Zhang Xiao-Xue, Jin Qing-Lo |
| Association between five types of Tumor Necrosis Factor-? gene polymorphism and hepatocellular carcinoma risk: a meta-analysis. BMC cancer 2020 Nov 20 (1): 1134. Wungu Citrawati Dyah Kencono, Ariyanto Fis Citra, Prabowo Gwenny Ichsan, Soetjipto , Handajani Ret |
| Association between the Interleukin-10 -1082 G/A polymorphism and risk of hepatocellular carcinoma. African health sciences 2020 Mar 20 (1): 351-358. Wang Yingwei, Hu Peiya |
| Methylenetetrahydrofolate reductase C677T (Ala>Val, rs1801133 C>T) polymorphism decreases the susceptibility of hepatocellular carcinoma: a meta-analysis involving 12,628 subjects. Bioscience reports 2020 Feb . Zhang Sheng, Jiang Jiakai, Tang Weifeng, Liu Longg |
| Combined Effect of PNPLA3, TM6SF2, and HSD17B13 Variants on Risk of Cirrhosis and Hepatocellular Carcinoma in the General Population. Hepatology (Baltimore, Md.) 2020 3 72 (3): 845-856. Gellert-Kristensen Helene, Richardson Tom G, Davey Smith George, Nordestgaard Børge G, Tybjaerg-Hansen Anne, Stender Stef |
| HSD17B13 rs72613567 protects against liver diseases and histological progression of nonalcoholic fatty liver disease: a systematic review and meta-analysis. European review for medical and pharmacological sciences 2020 9 24 (17): 8997-9007. Wang P, Wu C-X, Li Y, Shen |
| Identification of RASSF1A promoter hypermethylation as a biomarker for hepatocellular carcinoma. Cancer cell international 2020 12 20 (1): 547. Xu Gang, Zhou Xiaoxiang, Xing Jiali, Xiao Yao, Jin Bao, Sun Lejia, Yang Huayu, Du Shunda, Xu Haifeng, Mao Yil |
| Incidence and risk of proteinuria associated with newly approved vascular endothelial growth factor receptor tyrosine kinase inhibitors in cancer patients: an up-to-date meta-analysis of randomized controlled trials. Expert review of clinical pharmacology 2020 2 13 (3): 311-320. Zhang Wei, Feng Li-Jin, Teng Fei, Li Yan-Hong, Zhang Xi, Ran Yu- |
| Meta-analysis: Association between hepatitis B virus preS mutation and hepatocellular carcinoma risk. Journal of viral hepatitis 2020 9 28 (1): 61-71. Wungu Citrawati Dyah Kencono, Ariyanto Fis Citra, Prabowo Gwenny Ichsan, Soetjipto Soetjipto, Handajani Ret |
| PNPLA3 rs738409 is not associated with the risk of hepatocellular carcinoma and persistent infection of hepatitis B virus (HBV) in HBV-related subjects: A case-control study and meta-analysis on Asians. Gene 2020 3 742 144585. Wang Peng, Wu Chunxi, Li Ying, Gong Yajie, Shen |
| Tumor Necrosis Factor-Alpha Gene Promoter (TNF-? G-308A) Polymorphisms Increase the Risk of Hepatocellular Carcinoma in Asians: A Meta-Analysis. Critical reviews in oncogenesis 2020 25 (1): 11-20. Verma Henu Kumar, Merchant Neha, Bhaskar L V K |
| XPD Polymorphisms and Risk of Hepatocellular Carcinoma and Gastric Cancer: A Meta-Analysis. Technology in cancer research & treatment 0 20 1533033821990046. Zhou Qiang, Fu Yu, Wen Lijia, Deng Yu, Chen Junhong, Liu K |
- Page last reviewed:Feb 1, 2023
- Page last updated:Mar 22, 2023
- Content source: